Anna Hallersten is Head Regulatory Policy Europe at Roche Diagnostics, and elected Co-Chair of the IVD Regulatory Affairs Committee at MedTech Europe.
Anna Hallersten is a lawyer and public affairs practitioner specialized in the EU regulatory framework for healthcare- and consumer products. She has 18 years experience in health policy in the private- and public health sectors.
She served as Head Regulatory Policy for Roche Diagnostics (2017-present), Public Affairs Director for SFL Regulatory Affairs & Scientific Communication (2010-2017), Vice-Chair for EuropaBio’s Personalised Medicine WG (2015-16), International Public Policy Manager for F. Hoffmann-La Roche (2007-2010), Public Affairs Manager for Fleishman Hillard (2005-2006), Stagiaire at the European Commission SANTE (2005) and as Legal Adviser for Jordbruksverket, the Swedish competent authority for agriculture (2002-2004)
Anna holds a Master of Science in Commercial Law from Jönköping International Business School (JIBS), Sweden.